Skip to content
Cytognomix Logo
We find and validate mutations that others cannot
  • Home
  • Mission
    • Challenges in genomics: our solutions
  • Products
    • Biodosimetry: Automated Dicentric Chromosome Identifier
      • Testing for Radiation Exposure
    • Mutation Forecaster®
      • Interpretation of mutations in next generation sequencing data: Shannon pipeline
        • Testimonials for the Shannon pipeline
      • Automated Splice Site and Exon Definition Server (ASSEDA)
        • Publications
      • Software for validation of predicted mRNA splicing mutations
        • Testimonials for Veridical
      • Cytognomix User Variation Database (CUVD)
    • Solution capture pools for targeted deep sequencing
    • Targeted array CGH
    • Single copy FISH
      • Customized scFISH probes
      • Standard SC-FISH probes
      • Subtelomeric SC-FISH probes Catalog
    • Product advantages
    • Product Gallery
  • Posts
  • Purchase
    • Pricing
  • Contact Us
  • About us
    • Intellectual Property
    • Applications
  • Resources
  • SiteMap
  • Menu

Monthly Archives: April 2017

April 18, 2017. US Patent 9,624,549 issued about chemotherapy target identification

Posted on April 18, 2017April 18, 2017 by Peter Rogan

US Patent 9,624,549 has been issued!
“Stable gene targets in breast cancer and use thereof for optimizing therapy. ” Peter K Rogan and Joan Knoll.    (link)

This technology is the basis of biochemically inspired chemotherapy prediction by machine learning (http://chemotherapy.cytognomix.com).

April 8, 2017. Presentation about chemotherapy outcome prediction

Posted on April 9, 2017April 9, 2017 by Peter Rogan

Rogan PK, Mucaki EJ, Baranova K, Dorman S, Knoll JHM. Predicting responses to chemotherapies by biochemically-inspired machine learning. Innovative Approaches to Optimal Cancer Care in Canada, Canadian Partnership against Cancer, Toronto, Apr. 6-8, 2017. (Link to abstract)

Recent Posts

  • March 25, 2025. Videos available about radiation biology.
  • January 25, 2024. Appreciation of Cytognomix’s COVID-19 research studies by the government of Ontario
  • Oct. 4, 2023. Radiobiology textbook published
  • Sept. 19, 2023. Democratizing ADCI as cloud-based software
A SiteOrigin Theme